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Asthma is a chronic disease of the airways 
  characterized by airway infl  ammation, hyper-
reactivity, and recurrent episodes of airfl  ow 
obstruction, and is often attributed to the acti-
vation of CD4+ Th2 cells (1). The failure of 
asthmatics to resolve infl  ammation in their 
  airways after exacerbations remains one of the 
most problematic features of the disease (1, 2). 
This persistent infl  ammation is believed to be a 
major contributor to the frequency and   severity 
of asthma exacerbations and to other character-
istics of asthma, including airway remodeling, 
smooth muscle hypertrophy, and airway hyper-
reactivity (AHR) (3). Infl  ammatory cell apop-
tosis is reduced in the airways and peripheral 
blood of asthmatics (4–6). These studies have 
led to the hypothesis that defects in infl  amma-
tory cell apoptosis may play a role in the inability 
of asthmatics to normally resolve Th2- mediated 
immune response.
It has been nearly two decades since the 
  discovery that T helper lymphocytes include 
two subsets (Th1, Th2) with diff  erent eff  ector 
functions mediated by unique patterns of cyto-
kine production (7). Studies that have exam-
ined the relative susceptibility of Th1 and Th2 
cells to Fas-mediated apoptosis have yielded 
confl  icting results. Initially, two groups of in-
vestigators using clones of Th1 and Th2 cells 
found little susceptibility of the Th2 clones to 
Fas-induced death (8, 9). Yet another group, 
using cells from TCR transgenic mice, re-
ported the equal susceptibility of Th1 and Th2 
cells to Fas activation-induced cell death, 
whereas   others found that Th2-skewed cells 
were resistant (10, 11). Overall, there are now 
several studies demonstrating that Th2 cells 
up-regulate c-FLIP, which protects them 
from Fas-mediated cell death (for review see 
reference 12). This up-regulation is thought to 
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Persistent airway infl  ammation, mucus production, and airway hyperreactivity are the major 
contributors to the frequency and severity of asthma. Why lung infl  ammation persists in 
asthmatics remains unclear. It has been proposed that Fas-mediated apoptosis of infl  am-
matory cells is a fundamental mechanism involved in the resolution of eosinophilic airway 
infl  ammation. Because infi  ltrating eosinophils are highly sensitive to Fas-mediated apopto-
sis, it has been presumed that direct ligation of Fas on eosinophils is involved. Here, we 
utilize adoptive transfers of T cells to demonstrate that the delayed resolution of eosino-
philia in Fas-defi  cient mice is a downstream effect of Fas defi  ciency on T cells, not eosino-
phils. Interestingly, the mice that received Fas-defi  cient T cells, but not the controls, 
developed a persistent phase of infl  ammation that failed to resolve even 6 wk after the last 
challenge. This persistent phase correlated with decreased interferon (IFN)𝗄 production by 
Fas-defi  cient T cells and could be reproduced with adoptive transfer of IFN𝗄-defi  cient 
T cells. These data demonstrate that Fas defi  ciency on T cells is suffi  cient for the develop-
ment of long-term allergic airway disease in mice and implies that deregulation of death 
receptors such as Fas on human T cells could be an important factor in the development 
and/or chronic nature of asthma.
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be the   result of a selective increase of PI-3K activity in Th2 
cells (13, 14). Furthermore, several groups have found that 
Th2 cells produce less Fas ligand (FasL) than Th1 cells (15, 
16), possibly as a result of diff  erential NFAT usage in Th2 
cells (16). A recent study found that ligation of CTLA-4 on 
Th2 cells protects them from Fas-mediated activation-
  induced cell death (17). Together, all of these in vitro studies 
suggest that Fas–FasL interactions might not play an impor-
tant role in the normal resolution of Th2 infl  ammatory 
  responses. Nevertheless, there are examples of in vivo Th2 
responses being augmented in Fas-defi  cient mice (18, 19) and 
the question of whether Th2 responses in vivo are regulated, 
at least in part, by Fas is still unclear.
To address the role of Fas in the regulation of Th2-
  mediated infl   ammation, we used a previously described 
  murine model of allergic airways disease and mice with ab-
normalities of the Fas signaling pathway (20). We found 
that Fas defi  ciency leads to a delayed resolution of Th2 
  infl  ammation. Furthermore, Fas defi  ciency, specifi  cally on 
T cells, is suffi   cient to induce delayed resolution and can actu-
ally lead to the induction of persistent lung Th2 infl  ammation 
lasting at least 6 wk. This chronic infl  ammation occurs after 
the acute response in the absence of additional antigen chal-
lenge and includes many pathological features characteristic 
of human asthma, including continued infl  ammatory cells in 
the airways, dramatic mucus production, and AHR. Interest-
ingly, although T cells from control mice that had resolved 
their airway and lung infl  ammation produced high levels of 
IFNγ upon antigen restimulation, Fas-defi  cient T cells from 
unresolved mice produced signifi  cantly less IFNγ. These data 
suggested that Fas defi  ciency on the T cells might lead to per-
sistent infl  ammation through a defect in the development of 
IFNγ-producing T cells that, in turn, may fail to eff  ectively 
down-regulate the Th2 response (21). In support of this hy-
pothesis, we demonstrate that the persistent infl  ammation can 
be reproduced by the adoptive transfer of IFNγ-defi  cient 
T cells instead of Fas-defi  cient T cells. These data demonstrate
that Fas–FasL interactions can regulate in vivo Th2 responses 
and suggest that immunotherapy directed at this pathway 
might be benefi  cial for chronic Th2-mediated diseases.
RESULTS
Resolution of airway infl  ammation is delayed in mice 
defi  cient in the Fas pathway
The role of proapoptotic surface molecules in the resolution 
of Th2-mediated airway infl   ammation is uncertain. To 
  address whether Fas is involved in the resolution of airway 
infl  ammation, we compared the timing of resolution after 
Schistosoma mansoni sensitization and challenge in Fas-  defi  cient 
(Lpr) and wild-type mice (all strains used in these experiments 
are on the C57BL/6 [B6] background). As reported previ-
ously, mice sensitized with S. mansoni eggs and challenged 
with SEA antigen develop a robust airway infl  ammation by 
4 d after the challenge, consisting of 70–75% of eosinophils, 
10–15% of T cells, and 10–15% macrophages (20, 22). We 
have previously established that eosinophilia in our model is 
totally dependent on both sensitization and challenge (22). In 
the absence of either the sensitization or the challenge, the 
composition of the small number of bronchoalveolar lavage 
(BAL) cells is predominantly macrophages and indistinguish-
able from BAL of mice without sensitization and challenge. 
To determine the length of time required to resolve the air-
way infl  ammation, the time course of airway infl  ammation 
in B6 mice was examined. Profound airway eosinophilia was 
still evident on day 7, but was mostly resolved by day 14 in 
most mice (Fig. 1 A). Although Lpr mice developed levels of 
airway infl  ammation equal to B6 at day 4 after challenge (Fig. 
1 B), at day 14 after challenge the Lpr mice had signifi  cantly 
higher numbers of infi  ltrating eosinophils and T cells (Fig. 
1 C). As we have reported previously for B6 mice, Lpr mice 
sensitized with S. mansoni eggs, but sham challenged with 
PBS, did not develop airway infl   ammation at either time 
point (Fig. 1, B and C). It should be noted that the sensitized 
and challenged Lpr mice had much less infl  ammation at day 
14 than at day 4, suggesting that factors other than the Fas 
pathway also play a role in the clearance of   airway infl  ammation 
Figure 1.  Resolution of airway infl  ammation is delayed in Fas-
defi  cient mice. (A) Time course of BAL eosinophilia in B6 mice. Sensitized 
and challenged mice were killed and BAL analyzed on day 4 (n = 11), day 7 
(n = 4), day 11 (n = 7), and day 14 (n = 16) after the last challenge. 
(B and C) Lpr and B6 mice were sensitized with inactivated S. mansoni eggs, 
challenged with SEA (10 μg/mouse), and killed on days 4 and 14 after the 
last challenge. Total numbers of BAL cells, CD3+ T cells, and eosinophils 
were measured. Control mice were sensitized with inactive eggs, but chal-
lenged with only PBS (depicted as “-”). Lpr and B6 mice developed similar 
profound airway infl  ammation as measured by eosinophil and T cell num-
bers at day 4 after challenge, but Lpr mice had failed to resolve their airway 
infl  ammation at day 14 (Day 4: B6 n = 7, Lpr n = 10; Day 14: B6 n = 11, 
Lpr n = 9). ***, P < 0.001, N.D. indicates cell number <103. Error bars 
represent SEM.JEM VOL. 203, May 15, 2006  1175
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in this model. However, the signifi  cant delay in resolution in 
the Lpr strain demonstrates that this process is, in part, regu-
lated by Fas–FasL interactions.
Fas-positive T cells are suffi  cient for normal resolution 
of airway infl  ammation
We proposed two hypotheses to account for our observation 
that defi  ciency of Fas impairs resolution of airway eosino-
philia. The fi  rst hypothesis was that eosinophils, which ex-
press the Fas receptor (23), are killed directly upon ligation 
with FasL. In this scenario, Fas-defi  cient B6.Lpr eosinophils 
would survive longer, leading to prolonged infl  ammation. 
The second hypothesis was that primarily T cells are regu-
lated by Fas–FasL interactions. In this scenario, Th2 cells in 
the Lpr mice would survive longer as the result of absence of 
Fas expression, and these cells might indirectly prolong airway 
eosinophilia by increased or persistent production of eosino-
phil prosurvival cytokines such as IL-5.
To distinguish between these possibilities, we used an 
adoptive transfer model to “design” mice with diff  erential 
expression of Fas on eosinophils and T cells. Lymph node 
T cells from either B6 mice or Lpr mice were adoptively 
transferred into B6.Rag−/− mice. Because eosinophil pro-
duction occurs in the bone marrow and does not require 
Rag-1 expression, the resulting mice have eosinophils with 
the genotype of the recipient, whereas T cells have the geno-
type of the donor strain. Thus, the adoptively transferred 
mice had normal expression of Fas on their eosinophils 
(as well as other nonlymphoid cells), whereas expression of 
functional Fas on T cells depended on the donor mouse type 
used (B6 vs. Lpr). Mice that received B6 T cells (B6>Rag−/−) 
before sensitization and challenge with S. mansoni had a simi-
lar course of infl  ammation as found previously in normal B6 
(Fig. 1 A and not depicted). Mice that received Lpr T cells 
(Lpr>Rag−/−) before being sensitized and challenged had 
similar high BAL eosinophil and CD3 T cell counts at day 4 
as sensitized and challenged B6>Rag−/− mice (Fig. 2 A). 
However, strikingly, at day 14 as well as day 21, mice given 
Lpr T cells had signifi  cantly more airway infl  ammation com-
pared with the B6 T cell transferred mice (Fig. 2, B and C).
One possible caveat of these studies is that donor eosino-
phils or eosinophil progenitors could be transferred with the 
enriched lymph node T cells. To confi  rm that airway eosino-
phils were produced from recipient progenitors, adoptive 
transfers were performed with CD45 congenic mice. Lymph 
node cells from congenic B6.CD45.1 mice were transferred 
into B6.Rag−/− (CD45.2) recipients. After the mice were 
sensitized and challenged, BAL was performed and the cells 
were analyzed for CD45 expression to determine their source. 
The infl  ammatory cells stained positively for either CD45.1 
or CD45.2, but not both (Fig. 2 D, left). As expected, the 
CD3+ T cells derive from the CD45.1+ donor population 
(Fig. 2 D, middle). However, the eosinophil (CCR3+) cells 
are CD45.1 negative (Fig. 2 D right), thus demonstrating that 
they are recipient derived. We did detect a small number 
of CCR3+ cells that derive from the donor; however, these 
cells are also CD3+ and therefore represent a previously de-
scribed small population of T cells that express CCR3 (24). 
Together, these data confi  rm that in our adoptive transfer 
model, eosinophils are predominantly, if not totally, derived 
from the recipients. Thus, the B6.Rag−/− mice adoptively 
transferred with Lpr donors possessed Fas-positive eosino-
phils and Fas-defi   cient lymphocytes. Together, these data 
validate the adoptive transfer model and demonstrate that 
Fas-defi  cient T cells are suffi   cient to prolong infl  ammation 
despite normal Fas expression on eosinophils.
Increased Th2 cytokine production is found 
at later time points in lung tissue of sensitized 
and challenged Lpr>Rag−/− mice
To determine whether the extended infl  ammation was me-
diated by Th2 cells, we compared cytokine levels in the lung 
Figure 2.  Fas-positive T cells are suffi  cient for normal resolution 
of airway infl  ammation. B6 and Lpr T cells were adoptively transferred 
into B6.Rag−/− mice 1 d before sensitization (noted as B6>Rag−/− and 
Lpr>Rag−/−, respectively). The mice were killed on (A) day 4 (B6, n = 15; 
Lpr, n = 11), (B) day 14 (B6, n = 15; Lpr, n = 13), and (C) day 21 (B6, n = 6; 
Lpr, n = 7) after the fi  nal challenge and the BAL was analyzed. (D) B6.CD45.1 
donor cells were adoptively transferred into B6.Rag−/− (CD45.2) recipi-
ents, sensitized, and challenged, and BAL was harvested 4 d after the fi  nal 
challenge. BAL cells were stained with anti-CD45.1, CD45.2, CD3, and 
CCR3 antibodies. The data presented in D are representative of two inde-
pendent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars 
represent SEM.1176  REGULATION OF TH2-MEDIATED AIRWAY INFLAMMATION | Tong et al.
tissue between sensitized and challenged Lpr>Rag−/− and 
B6>Rag−/− mice. A signifi  cant diff  erence in IL-4 and IL-5 
levels between B6>Rag−/− and Lpr>Rag−/− mice was 
found at day 14 after the last challenge (Fig. 3 A). Further-
more, continued production of both IL-5 and IL-4 was found 
at day 21 from Lpr>Rag−/−, but not B6>Rag−/− lung tissue 
(Fig. 3 B). Although a low level of IFNγ was found in lung 
tissue, no signifi  cant diff  erence between these two groups 
was observed (unpublished data). These fi  ndings, along with 
the presence of eosinophils, establishes the Th2 nature of the 
days 14 and 21 airway and lung infl  ammation in the sensi-
tized and challenged Lpr>Rag−/− mice.
Fas defi  ciency on T cells leads to increased 
mucus production
Increased mucus production is a common pathophysiological 
manifestation associated with asthma and is an important con-
tributor to airway obstruction, which in its most severe form 
can lead to mortality. Goblet cell metaplasia and mucus produc-
tion were determined by PAS staining of histological sections 
at day 21. As seen in Fig. 4 A, PAS staining in the sensitized 
and challenged Lpr>Rag−/− bronchi was noticeably intense, 
whereas very little PAS staining was seen in the sensitized and 
challenged B6>Rag−/− bronchi. When histological sections 
were scored as described in detail in Materials and methods, we 
found that a signifi  cantly higher percentage of bronchi showed 
PAS staining in the sensitized and challenged Lpr>Rag−/− 
mice compared with the sensitized and challenged B6>Rag−/− 
mice (Fig. 4 B). Furthermore, the severity of the goblet cell 
metaplasia was also signifi  cantly higher in the bronchi from 
the sensitized and challenged Lpr>Rag−/− mice (Fig. 4 C). 
Infl  ammation was further evaluated by scoring hematoxylin 
and eosin sections as described in detail in Materials and meth-
ods for the relative amounts of perivascular and peribronchial 
infl   ammation. The lungs from sensitized and challenged 
Lpr>Rag−/− mice showed more severe infl  ammation com-
pared with sensitized and challenged B6>Rag−/− mice (Fig. 
4 D). Together, these data demonstrate that both infl  ammation 
and mucus production continues through day 21 in sensitized 
and challenged Lpr>Rag−/− mice.
Fas defi  ciency on T cells leads to AHR
AHR is a hallmark of asthma and is often associated with in-
creased airway infl  ammation (25, 26). To investigate if the 
persistent airway infl   ammation in Lpr>Rag−/− mice also 
leads to AHR, we measured respiratory system resistance 
Figure 3.  Increased Th2 cytokine production in the lung tissue of 
Lpr>Rag−/− mice. (A and B) Cytokine levels in lung tissue lysate at days 
14 and 21 are shown. Cytokines were measured by Cytometric Bead Array 
as described in Materials and methods. The data are from one representa-
tive out of three experiments. Three to fi  ve mice per group per time point 
were analyzed. *, P < 0.05; **, P < 0.01. Error bars represent SEM.
Figure 4.  Increased mucus production in Lpr>Rag−/− mice. (A) Rep-
resentative sections of lung at day 21. Lung tissues from B6>Rag−/− and 
Lpr>Rag−/− mice were fi  xed in 4% paraformaldehyde and embedded in 
paraffi  n. Sections were stained PAS for analysis of mucus-containing cells. 
(B) Quantifi  cation of the number of positive bronchi and (C) severity of the 
abundance of PAS-positive mucus-containing cells. The PAS-positive bron-
chi scoring and the relative scores are described in detail in Materials and 
methods. (D) Perivascular and peribronchial infl  ammation were scored as 
described in Materials and methods. Six to seven mice per group were ana-
lyzed. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars represent SEM.JEM VOL. 203, May 15, 2006  1177
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(Rrs) changes in response to methacholine aerosol at days 4, 
14, and 21 after last challenge. Rag−/− mice that did not re-
ceive any T cells, but were sensitized and challenged were 
used as controls at days 4 and 14. As previously demonstrated 
by others, in the absence of T cells, the Rag−/− mice fail to 
develop any eosinophilic airway or lung infl  ammation  or 
AHR in our model (reference 27 and unpublished data). In 
both sensitized and challenged Lpr>Rag−/− and B6>Rag−/− 
mice, Rrs responses at day 4 to inhaled methacholine were 
greater than in control sensitized and challenged Rag−/− 
mice, but there was no signifi  cant diff  erence in airway re-
sponsiveness between Lpr>Rag−/− and B6>Rag−/− mice at 
this time (Fig. 5 A). In marked contrast, at days 14 and 21, 
Lpr>Rag−/− mice remained hyperresponsive to methacho-
line, whereas sensitized and challenged B6>Rag−/− mice re-
turned to normal responsiveness by day 14 (Fig. 5, B and C). 
Hence, after the induction of Th2-mediated airway infl  am-
mation, Fas defi  ciency on T cells leads to prolonged AHR.
Fas defi  ciency on T cells leads to persistent 
airway infl  ammation
The partial resolution of airway infl  ammation and cholinergic 
hyperresponsiveness in sensitized and challenged Lpr>Rag−/− 
mice at day 21 implied that complete resolution might just 
be delayed, rather than fully defective. To determine when 
complete resolution, similar to sensitized and challenged 
B6>Rag−/− mice occurs, we tested several later time points. 
To our surprise, the BAL eosinophil counts in the sensitized 
and challenged Lpr>Rag−/− mice at day 28, and even 2 wk 
later at day 42, were still signifi  cantly higher than the sensi-
tized and challenged B6>Rag−/− mice (Fig. 6 A). BAL T cell 
counts remained higher in sensitized and challenged 
Lpr>Rag−/− mice at day 28, but matched the B6>Rag−/− 
mice at day 42 (Fig. 6 A). Strikingly, histological evaluation of 
the lungs from sensitized and challenged Lpr>Rag−/− mice at 
these later time points revealed dramatically severe infl  amma-
tion and mucus production compared with sensitized and 
challenged B6>Rag−/− mice (Fig. 6 B). Even at day 42, 
Lpr>Rag−/− mice remained highly infl  amed,  whereas 
B6>Rag−/− mice had mild or no infl  ammation (Fig. 6 B, 
panels 2 and 5, and C). Goblet cell metaplasia and mucus pro-
duction were also scored on PAS-stained sections at these 
time points. Lpr>Rag−/− mice still had dramatically intense 
positive PAS staining bronchi at day 42 (Fig. 6 B, panels 3 and 
6, and D). Furthermore, the percentage of PAS positive bron-
chi and the severity of the goblet cell metaplasia were also sig-
nifi  cantly higher in the sensitized and challenged Lpr>Rag−/− 
mice compared with the sensitized and challenged B6>Rag−/− 
mice at days 28 and 42 (Fig. 6 D). Finally, increased airway 
reactivity was found in Lpr>Rag−/− mice compared with 
sensitized and challenged B6>Rag−/− at day 42 (Fig. 6 E), 
  although both groups of mice had reduced reactivity com-
pared with earlier time points (Fig. 5). Together, these data 
demonstrate that the sensitized and challenged Lpr>Rag−/− 
mice develop a chronic infl  ammatory response that includes 
many of the major features of human asthma.
Recent studies have suggested that Fas-defi  cient T cells 
may cause lung infl  ammation independent of antigen sen-
sitization and challenge (28). To control for this possibility, 
Rag−/− mice were adoptively transferred with either B6 or 
Lpr T cells, but were not sensitized or challenged. These 
control mice were killed 8 wk later (which is the time equiv-
alent of day 42 after the last challenge in our sensitized and 
challenged mice) and evaluated histologically. No airway in-
fl  ammation or mucus production was found in any of these 
control mice (Fig. 6 B, panels 1 and 4). Thus, this control 
experiment demonstrates that the infl  ammation found in the 
sensitized and challenged Lpr>Rag−/− mice at day 42 is not 
the result of the mere presence of Fas-defi  cient T cells, but to 
an antigen-driven eff  ect of the Lpr T cells.
Figure 5.  Fas defi  ciency on T cells leads to AHR. Respiratory system 
resistance (Rrs) to methacholine was measured at days 4 (A), 14 (B), and 
21 (C) after the last challenge. Control Rag−/− mice, without T cell adop-
tive transfer, but with sensitization and challenge are shown. Analysis of 
variance was used to analyzed the differences in airway response to 
methacholine between B6>Rag−/− and Lpr>Rag−/− mice. Three to eight 
mice per group per time point were analyzed. *, P < 0.05. Error bars 
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Persistent airway infl  ammation in Lpr>Rag−/− mice is not 
the result of lymphoproliferation of CD4−CD8− Lpr T cells 
in the chronic phase
Lpr mice have an inherited disorder of the immune system 
that causes massive lymphoproliferation at even early stages of 
life; for instance, it has been found that the pathogenic 
CD4−CD8− CD3 T cells develop over time in Lpr strains 
(29). To determine if it is possible that Lpr T cells have de-
veloped other characteristics as a “side eff  ect” of defective Fas 
that are causing the persistent airway infl  ammation in our 
model, we examined the proportion of CD4+ and CD8+ T 
cells and the phenotype of T cells from B6 and Lpr mice be-
fore adoptive transfer. The proportions of CD4+ and CD8+ 
cells are normal between B6 and Lpr mice as shown in Fig. 
7 A, and we also didn’t fi  nd any enhanced numbers of double 
negative (DN) and double positive (DP) Lpr T cells at mice 
Figure 6.  Fas defi  ciency on T cells leads to persistent airway infl  am-
mation and AHR. (A) BAL T cell and eosinophil counts were determined for 
days 8, 11, 28, and 42. The data from Fig. 2 for days 4, 14, and 21 are also 
included to provide a more complete picture of the entire time course that 
was tested. (B) Representative sections from B6>Rag−/− (panels 1–3) and 
Lpr>Rag−/− (panels 4–6) mice are shown. In panels 2–3 and 5–6, the mice 
were sensitized and challenged (SCH) as described in Materials and methods 
and killed 42 d after the last challenge (which was 57 d after the adoptive 
transfer of the T cells). In panels 1 and 4, the mice were adoptively trans-
ferred, but left without sensitization and challenging for 57 d to control for 
a nonspecifi  c effect of the adoptive transfer of Lpr T cells on lung histology. 
The sections were stained with PAS or hematoxylin and eosin as noted. 
(C) Perivascular and peribronchial infl  ammation and (D) goblet cell metapla-
sia was scored as described in Materials and methods. (E) Respiratory 
  system resistance (Rrs) to methacholine was measured at day 42 after last 
challenge. In all sections, four to fi  ve mice per group per time point were 
analyzed. Data in A–D are representative of two separate experiments. 
*, P < 0.05, **, P < 0.01, ***, P < 0.001. Error bars represent SEM.JEM VOL. 203, May 15, 2006  1179
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aged 5–7 wk old. This age of mice is used for T cell isolation 
from LN for adoptive transfer. More importantly, we also 
examined the phenotype of T cells from the BAL, spleen, 
lungs, and LN at days 28 and 42 in B6>Rag−/− and 
Lpr>Rag−/− mice after the last challenge. It is notable 
that the sum of the CD4+ and CD8+ T cells is >97% of 
total CD3+ T cells in both groups and that very few 
CD3+CD4−CD8− (DN) and CD3+CD4+CD8+(DP) T 
cells were observed in either the BAL, spleen (Fig. 7, B and 
C), lungs, and LN (not depicted) in Lpr>Rag−/− mice. Our 
data strongly suggest that persistent airway infl  ammation in 
Lpr>Rag−/− mice is not the result of the development of 
DN and DP pathological T cells populations.
Failure to resolve airway infl  ammation is correlated 
with decreased IFN𝗄 production by Fas-defi  cient T cells
To determine the nature of the T cell response at day 42, 
BAL and lung T cells were restimulated with SEA overnight 
on ELISPOT plates for IFNγ and IL-5 (Fig. 8 A). IL-5–pro-
ducing cells were not detected from the BAL of either 
B6>Rag−/− or Lpr>Rag−/− mice (unpublished data) and 
were equivalent in the lungs from the two groups of mice 
(Fig. 8 A). Interestingly, the number of antigen-responsive 
IFNγ-producing cells was signifi   cantly greater in the 
B6>Rag−/− BAL and lung cell cultures compared with 
the Lpr>Rag−/− cultures (Fig. 8 A). To further investigate 
the source of IFNγ in the B6>Rag−/− mice, we repeated the 
experiment, and on day 28, performed intracellular staining 
for IFNγ. As seen at day 42, day 28 lung T cells from 
B6>Rag−/− mice produced more IFNγ+ cells than 
Lpr>Rag−/− mice and, interestingly, the IFNγ-producing 
cells in the lungs were mostly CD4+ T cells (Fig. 8 B). Thus, 
although neither B6>Rag−/− nor Lpr>Rag−/− mice pro-
duced a signifi  cant IFNγ response at the peak of infl  amma-
tion (Fig. 3 and not depicted), over time the B6>Rag−/−, 
but not the Lpr>Rag−/− mice, develop antigen-specifi  c 
IFNγ-producing CD4 T cells.
Similar to Fas-defi  cient T cells, IFN𝗄-defi  cient T cells 
can induce persistent airway infl  ammation
We hypothesized that the development of IFNγ+ CD4+ T 
cells may be a key mechanism involved the timely resolution 
in the sensitized and challenged B6>Rag−/− mice and that 
the failure to develop these IFNγ+ CD4+ T cells may explain 
the persistent infl   ammation found in sensitized and chal-
lenged Lpr>Rag−/− mice. To test this hypothesis, IFNγ−/− 
T cells were transferred to Rag−/− mice (IFNγ−/−>Rag−/−), 
and sensitized and challenged as described in previous para-
graphs. We found that there is a similar level of airway 
  infl   ammation at day 4 between IFNγ−/−>Rag−/− and 
B6>Rag−/− mice. Interestingly, similar to the Lpr>Rag−/− 
mice, IFNγ−/−>Rag−/− mice have a delayed resolution of 
eosinophilia in the airway at days 14 and 28 (Fig. 9 A). At day 
28 after the last challenge, we also observed signifi  cantly 
higher levels of lung, peribronchial, and perivascular infl  am-
mation in IFNγ−/−>Rag−/− mice than in B6>Rag mice 
(Fig. 9 B). These data demonstrated that IFNγ production 
by T cells is involved in the resolution of airway infl  amma-
tion in the B6>Rag−/− mice and suggested that the failure 
of Lpr T cells to produce IFNγ in the Lpr>Rag−/− mice 
may play an important role in their inability to resolve Th2-
mediated infl  ammation.
D  I  S  C  U  S  S  I  O  N 
Why asthmatics fail to resolve infl  ammation in their airways 
remains one of the unsolved problems in asthma (1, 2). Persis-
tence of T cells and eosinophils in bronchial biopsies was 
found in persistent asthma and even in intermittent asthma (4). 
Figure 7.  Persistent airway infl  ammation in Lpr>Rag−/− mice is not 
the result of lymphoproliferation of the pathological CD4−CD8− Lpr 
T cells. (A) The percentage of CD4+ and CD8+ T cells and the phenotype of 
T cells from B6 and Lpr mice were examined after T cell isolation from B6 
and Lpr mice before adoptive transfer. CD4 and CD8 expression was analyzed 
from the gated CD3 T lymphocytes. (B and C) The percentage and phenotype 
of CD4+ and CD8+ T cells from the BAL and spleens at days 28 and 42 after 
the last challenge were examined in B6>Rag−/− and Lpr>Rag−/− mice.1180  REGULATION OF TH2-MEDIATED AIRWAY INFLAMMATION | Tong et al.
These fi   ndings led us to question how Th2 infl  ammatory 
  responses normally resolve in murine models of asthma. The 
objective of this investigation was to determine the poten-
tial role of the death receptor, Fas (CD95), in antigen-
  induced Th2-mediated airway infl  ammation in mice. We 
fi  nd that Fas+ T cells play a pivotal role in the resolution of 
airway   infl  ammation, mucus production, and AHR. These 
fi  ndings in mice may shed light on potential mechanisms of 
asthma pathogenesis.
Several studies have suggested that dysregulated apoptosis 
of eosinophils may be involved in human asthma. Eosinophils 
express the Fas receptor and undergo apoptosis in vitro and in 
vivo when bound by FasL or an agonizing antibody (30–32). 
However, eosinophils from asthmatic lungs undergo less apop-
tosis than normal controls and express more Bcl-2, and treat-
ment of human asthma with corticosteroids leads to an increase 
in the number of apoptotic eosinophils (33–35). In fact, asthma 
severity has been directly correlated to reduced eosinophil 
apoptosis in induced-sputum samples (35). Yet, how eosino-
phil apoptosis is regulated in asthma remains undefi  ned.
In our study, we demonstrated that Fas-defi  cient Th2 
cells were suffi   cient to drive the extended course of airway 
infl  ammation in sensitized and challenged Lpr mice. These 
data suggest that the fate of eosinophils in the lungs and air-
ways is largely dependent on T cells. Our results do not dis-
count the eff  ect of eosinophil apoptosis mediated by Fas or 
other mechanisms. Furthermore, because we have not exam-
ined eosinophil apoptosis directly in our model, we cannot 
exclude the possibilities that the lack of resolution is the result 
of lack of clearance of eosinophils or to enhanced or persis-
tent recruitment of cells. Nevertheless, our fi  ndings suggest 
that resolution of airway eosinophilia infl  ammation is largely 
downstream of Fas expression on T cells. In human asthma, 
there were several reports that T cells also undergo less apop-
tosis. One report found that mitogen-stimulated peripheral 
blood T cells from asthmatic subjects failed to undergo the 
same degree of Fas-mediated apoptosis as T cells from the 
normal control subjects, thereby providing direct evidence 
for a defect in programmed cell death in the pathogenesis of 
asthma (5). Additionally, defective expression of Fas mes-
senger RNA and Fas receptor was found on pulmonary T cells 
from patients with asthma (36). De Rose et al. reported that 
the defect in IFNγ production involved in the allergic im-
mune response may be responsible for a decrease in apoptosis 
of allergen-activated T lymphocytes in the airways of atopic 
asthmatic patients (37). Thus, our results in this new model 
have direct correlations with the fi  ndings of these studies in 
human asthma. In addition to dysfunctional Fas pathway on 
T cells, markedly reduced Fas ligand mRNA and protein in 
the airway epithelium during allergic airway infl  ammation in-
duced by OVA in mice may be also involved in the pathogenesis 
of certain infl  ammatory conditions of the airway (38).
Figure 8.  Failure to resolve airway infl  ammation is correlated with 
decreased IFN𝗄 production by Fas-defi  cient T cells. (A) BAL cells and 
lung T cells were restimulated with SEA for 24 h on ELISPOT plates specifi  c 
to measure IFNγ and IL-5. Data are expressed as positive points per well. 
Three or six wells per group were averaged and means ± SEM are shown. 
Higher numbers of IFNγ-producing cells were measured in cultures of 
day 42 B6>Rag−/− BAL and lung cells stimulated with exogenous SEA 
antigen (5 μg/ml; left and middle). Similar numbers of IL-5–producing 
cells were measured in cultures of day 42 Lpr>Rag−/− and B6>Rag−/− 
lung T cells with or without exogenous SEA antigen (right). (B) Lung 
T cells were restimulated with PMA and ionomycin for 4 h. The cells were 
stained with anti-IFNγ antibody of intracellular cytokine staining. Lung 
T cells from Lpr>Rag mice had sevenfold less IFNγ+ T cells than those 
from B6>Rag−/− mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 203, May 15, 2006  1181
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Persistent Th2 infl  ammation has been one of the most 
diffi     cult aspects of authentic asthma to model in animals. 
Many models for persistent infl  ammation require continued 
antigen exposure for long periods of time. When antigen ex-
posure is ended, airway remodeling and AHR can remain for 
3–4 wk; however, infl  ammation resolves quickly after the last 
antigen challenge (39–41). Recently, there has been the de-
velopment of other models that use either mite allergens (42) 
or conventional OVA allergen with new technology for 
aerosol delivery (40). However, all of these models require 
20–40 nebulizations after one to two immunizations. Mice 
with a targeted deletion of the T-bet gene spontaneously 
demonstrated multiple physiological and infl  ammatory fea-
tures characteristic of asthma (43). Transgenic mice that 
overexpress IL-5 (44), IL-9 (45), IL-11 (46), and IL-13 (47) 
showed AHR, eosinophilic infl  ammatory response, and col-
lagen deposition in the airways, indicating that chronic expo-
sure to Th2 cytokines could also induce airway remodeling. 
Airway infl  ammation in these animal models occurs sponta-
neously without any antigen exposure. Thus, current meth-
ods for inducing chronic airway infl  ammation fall into two 
categories: those models in which the mice are repeatedly 
challenged for weeks or even months, and models of geneti-
cally manipulated mice that develop a spontaneous Th2-type 
airway infl  ammation in the absence of allergen exposure.
In this study, we now present data on a third method of 
inducing persistent airway infl  ammation. This novel model is 
not spontaneous, but allergen-induced, yet only requires two 
challenges after a single sensitization. Although it has been 
proposed that the persistent infl  ammation found in asymp-
tomatic asthmatics is the result of chronic low level exposure 
to allergens, it is just as likely that the persistent infl  ammation 
in asymptomatic asthmatics is the result of defects in resolu-
tion of airway infl  ammation. Thus, the Fas-defi  cient T cell 
mice represent an altogether new model of persistent airway 
infl  ammation that does not require continuous challenges to 
induce this key feature of asthma.
Recently, Rajewsky et al. published their fi  ndings on ab-
lation of Fas specifi  cally in the T cell compartment (28). They 
reported that between 8 and 12 mo, these mice develop se-
vere pulmonary fi  brosis and accumulation of infl  ammatory 
cells. Although T cell–specifi  c Fas−/− mice and our adop-
tively transferred Lpr>Rag−/− mice are both Fas defi  cient on 
only T cells, the timing and type of lung pathology diff  ers in 
the two models. Nevertheless, to test whether our fi  ndings 
could be explained by spontaneous lung disease, we adop-
tively transferred B6 and Lpr T cells into Rag−/− mice but 
did not sensitize and challenge these animals. After 8 wk, no 
evidence of infl  ammation could be found (Fig. 6 B). Thus, it 
is highly unlikely that persistence of Th2-type infl  ammation 
in our model is related to the pulmonary fi  brosis and infl  am-
mation that develops at a much later stage of life in T cell 
specifi  c Fas−/− mice.
Our study is supported by previous work from Gelfand 
et al., who demonstrated that AHR is increased in OVA-
sensitized and challenged Fas-defi  cient mice compared with 
wild type at day 4 after the last challenge and that blockade 
of infl  ammation with anti–IL-5 treatment attenuates the 
  response (18). Interestingly, unlike our fi  ndings, these inves-
tigators did not fi  nd a delay in the resolution of infl  ammation 
in the Lpr mice. More importantly, in our adoptive transfer 
model, we now demonstrate that Fas defi  ciency specifi  cally 
on T cells is suffi   cient to prolong infl  ammation despite  normal 
Fas expression on eosinophils.
To investigate the possible mechanisms involved in the 
development of persistent airway infl  ammation in sensitized 
and challenged Lpr>Rag−/− mice, T cell function was stud-
ied. We found that lung T cells from B6>Rag−/− mice pro-
duced more IFNγ+ cells than lung T cells from Lpr>Rag−/− 
mice and, interestingly, that the IFNγ-producing cells in the 
lungs were mostly CD4+ T cells. To test the hypothesis that 
development of IFNγ+ CD4+ T cells may be a key mecha-
nism involving timely resolution, IFNγ−/− T cells were 
transferred to Rag−/− mice. We found that IFNγ−/−>Rag−/− 
mice have a delayed resolution of eosinophilia and lung peri-
bronchial perivascular infl  ammation (Fig. 9). These data sug-
gest that the failure of Lpr T cells to produce IFNγ in the 
Lpr>Rag−/− mice may play an important role in their in-
ability to resolve their Th2-mediated infl  ammation. These 
Figure 9.  IFN𝗄-defi  cient T cells can induce persistent airway 
  infl  ammation similar to Lpr T cells. (A) B6 and IFNγ−/− T cells were 
adoptively transferred into Rag−/− mice 1 d before sensitization. BAL was 
analyzed on days 4, 14, and 28 after the last challenge. IFNγ−/−>Rag and 
B6>Rag−/− mice produced similar levels of airway infl  ammation at day 4, 
but at days 14 and 28, higher levels of eosinophils were found in the 
IFNγ−/−>Rag−/− mice compared with B6>Rag−/− mice. (B) Perivascular 
and peribronchial infl  ammation was scored as described in Materials and 
methods. At days 14 (not depicted) and 28 (B), signifi  cantly higher levels 
of lung peribronchial and perivascular infl  ammation was observed in 
IFNγ−/−>Rag−/− mice than in B6>Rag−/− mice. Three to four mice per 
group were analyzed. *, P < 0.05. Error bars represent SEM.1182  REGULATION OF TH2-MEDIATED AIRWAY INFLAMMATION | Tong et al.
results were also consistent with previous reports (21, 37, 48, 
49) in which Th1 T cells inhibited Th2-induced eosinophilia 
and mucus production. Why eff  ective antigen-specifi  c Th1 
cells fail to develop in the Lpr>Rag−/− mice remains un-
clear. In fact, several reports suggest that Fas defi  ciency leads 
to greater Th1 responses (for review see reference 12). Thus, 
further studies will be required to resolve these apparent con-
tradictory studies.
There has been much controversy over the role of Th1 
cells in asthma (for review see reference 1). Although some 
studies have suggested a protective role for Th1 cytokines in 
allergy and asthma (50, 51), other investigators have sug-
gested that Th1 cells enhance pulmonary infl  ammatory re-
sponses and AHR (52–54). In our model, the data clearly 
demonstrate that Th2 cells play a stimulating role in the early 
phase of the airway infl  ammation, but that Th1 cells play an 
inhibiting role in the chronic phase of airway infl  ammation. 
Nevertheless, the development of our novel animal model of 
asthma provides a new opportunity to study the mechanisms 
involved in chronic Th2 infl  ammation as well as the patho-
logical outcomes of this long-term infl  ammation. Further in-
vestigations in the role of Fas in regulating Th2 immunity 
may translate into better treatments for asthma and other 
Th2-mediated diseases.
MATERIALS AND METHODS
Animals. B6 mice were purchased from either The Division of Cancer 
Treatment at the National Cancer Institute or from The Jackson Laboratory. 
B6.MRL-Tnfrsf6lpr (Lpr), B6.129S7-Ifngtm1Ts/J (IFNγ−/−), B6.129S7-
Rag1tm1Mom (B6.Rag−/−), and B6.SJL-PtprcaPep3b/BoyJ (B6.CD45.1) mice 
were purchased from The Jackson Laboratory and bred and housed in a spe-
cifi  c pathogen-free barrier facility maintained by the University of Chicago 
Animal Resources Center. The studies reported here conform to the princi-
ples outlined by the Animal Welfare Act and the National Institutes of 
Health guidelines for the care and use of animals in biomedical research.
Antibodies and fl  ow cytometry. Anti–mouse CD3 (clone 17A2), CD4 
(clone L3T4), CD8 (clone 53–6.7), CD45.1 (clone A20), and CD45.2 
(clone 104) antibodies were obtained from BD Biosciences. Anti–mouse 
CCR3 antibody (clone 83101.111) was obtained from R&D Systems. Anti-
IFNγ–PE was obtained from eBioscience. For intracellular staining, the cells 
were fi  xed with 4% paraformaldehyde for 10 min after surface staining and 
washed 2× in permeabilization buff  er (0.03% saponin/PBS/0.25% gelatin). 
Staining antibodies, diluted to the predetermined concentration in permea-
bilization buff  er, were added to the samples, and the samples were incubated 
for 30 min at 4°C. The samples were washed and analyzed on a FACS LSR-II 
(Becton Dickinson).
S. mansoni sensitization and challenge. S. mansoni sensitization and 
challenge to induce murine allergic airway disease was described previously 
(20). In brief, S. mansoni eggs were harvested and SEA was produced as de-
scribed previously (55). At day −14, mice were immunized by i.p. injection 
of 5,000 inactivated S. mansoni eggs, which induced a natural Th2 response 
in the absence of active infection. A days −7 and 0, the mice were chal-
lenged with 10 μg of SEA by intranasal and intratracheal aspiration, respec-
tively. The mice were studied between 4 and 42 d after the last challenge. 
To ensure that they had not yet developed lymphoproliferative disease, Lpr 
and IFNγ−/− mice were used between 5–7 wk of age.
BAL analysis. BAL was performed by delivering 0.8 ml of cold PBS into 
the cannulated trachea and gently aspirating the fl  uid. The lavage was 
  repeated a total of four times to recover a total volume of 2.5–3 ml. The la-
vage was centrifuged and supernatant was stored at −20°C for cytokine 
analysis. The percentage of cell types found within BAL fl  uid was deter-
mined by FACS analysis with cell type–specifi  c markers.
Th1/Th2 cytokine determination in lung tissue. The lung tissue was 
weighed, homogenized in 500 μl 1× PBS containing protease inhibitors, 
and collected by centrifugation at 3,000 revolutions/min for 15 min. Cyto-
kines in the lung tissue were detected using a murine Th1/Th2 Cytometric 
Bead Array kit (BD Biosciences) according to manufacturer’s instructions, 
except that the beads were incubated in 10-fold more volume of lung lysate 
(500 μl) than recommended. The detection limits were 5 pg/ml for IL-4, 
5 pg/ml for IL-5, and 2.5 pg/ml for IFNγ.
ELISPOT. ELISA spot plates (Cellular Technology Limited) were coated 
with rat anti–mouse IL-5 and IFNγ antibodies (2 μg/ml) (BD Biosciences). 
Plates were blocked with PBS/0.1% BSA and washed with PBS. BAL and 
lung cells were cultured on the plates for 16 h at 37°C in the presence or ab-
sence of SEA (5 μg/ml). The ELISPOT plates were scanned by ImmunoSpot 
Series 2 Analyzer (Cellular Technology Limited).
Adoptive transfer. B6 and Lpr T cells were harvested from lymph nodes 
from donor mice and enriched by nonadherence to a nylon wool column. 
107 cells were adoptively transferred into each recipient intravenously. The 
purity by fl  ow cytometry was between 90 and 95% CD3+ T cells.
Histology. Lungs were removed from mice after BAL and fi  xed by immer-
sion into 4% paraformaldehyde. Lobes were sectioned sagitally, embedded in 
paraffi   n, cut into 5-μm sections, and stained with hematoxylin and eosin for 
analysis. An infl  ammation score was assigned in a blinded fashion by a pa-
thologist. The score of peribronchiolar and perivascular infl  ammation was 
determined as follows: 0, normal; 1, few cells; 2, a ring of infl  ammatory cells 
one cell layer deep; 3, a ring of infl  ammatory cells two to four cells deep; and 
4, a ring of infl  ammatory cells of more than four cells deep. Additional sec-
tions were stained with periodic acid schiff   (PAS) for analysis of mucus-
  containing cells. Scoring was performed by examining at least 20 consecutive 
fi  elds. Numerical scores for the abundance of PAS-positive goblet cells (56) 
in each airway were determined as follows: 0, <5% goblet cells; 1, 5–25%; 
2, 25–50%; 3, 50–75%; and 4, >75%, with 0 being negative and 1–4 being 
positive for PAS-staining bronchi.
Airway responsiveness. Methacholine challenge experiments were per-
formed at 4, 14, 21, and 42 d after the last antigen challenge. Rrs was mea-
sured through a computer-controlled small animal ventilator (Flexivent; 
SCIREQ) as described previously (57). Each mouse was challenged with in-
creasing doses of methacholine aerosol (0, 5, 10, 20, and 40 mg/ml in saline) 
for 12 s. After each challenge, Rrs was recorded during tidal breathing every 
10 s for 2 min. Maximum values of Rrs were taken and expressed in terms 
of percentage change from baseline after saline aerosol.
Statistical analysis. Graph generation and statistical analysis were  performed 
by using Prism software (version 4.00; GraphPad). Diff  erences  between 
groups for lung histology parameters, total BAL cells, BAL eosinophils, BAL 
T cells, and cytokine content in BAL fl  uid and lung tissues were determined 
by using an unpaired Student’s two-tailed t test. For analyses of the data on 
days 28 and 42 in Figs. 6 and 9, the more conservative (less powerful), 
Mann-Whitney nonparametric comparison was used. Error bars represent 
SEM. Two-way analysis of variance was used to analyze the diff  erences in 
airway response to methacholine among groups of mice. Statistical signifi  -
cance was claimed whenever *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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